The Insulin Receptor Talks to Glucagon?

Slides:



Advertisements
Similar presentations
Mitoconfusion: Noncanonical Functioning of Dynamism Factors in Static Mitochondria of the Heart Moshi Song, Gerald W. Dorn Cell Metabolism Volume 21, Issue.
Advertisements

Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
The Metabolic Basis of Pulmonary Arterial Hypertension Gopinath Sutendra, Evangelos D. Michelakis Cell Metabolism Volume 19, Issue 4, Pages (April.
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Volume 14, Issue 2, Pages (August 2011)
Sofie Hædersdal, MD, Asger Lund, MD, PhD, Filip K
Ghrelin—a new player in glucose homeostasis?
Novel SIRT1 Mutation Linked to Autoimmune Diabetes in Humans
Volume 17, Issue 5, Pages (May 2013)
Michael V. Berridge, Remy T. Schneider, Melanie J. McConnell 
All roads lead to FoxO Cell Metabolism
Insulin Secretion: Fatty Acid Signalling via Serpentine Receptors
Omega 3 Fatty Acids and GPR120
Pancreatic β cells: Responding to the matrix
Calcium Signaling and the Control of Dendritic Development
Safia Costes, Peter C. Butler  Cell Metabolism 
The Double Life of Irs Cell Metabolism
A Clock Ticks in Pancreatic β Cells
TCF7L2 and Diabetes: A Tale of Two Tissues, and of Two Species
VEGF-B Improves Metabolic Health through Vascular Pruning of Fat
High T Gives β Cells a Boost
Human Platelet Lipidomics: Variance, Visualization, Flux, and Fuel
Independent Control of Aging and Axon Regeneration
Insulin biosynthesis: The IREny of it all
Volume 26, Issue 1, Pages 6-7 (July 2017)
The CAMplexities of Central Ghrelin
Life Is Short, if Sweet Cell Metabolism
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Diabetes Mellitus and the β Cell: The Last Ten Years
Autophagy: A Sweet Process in Diabetes
Update on cystic fibrosis-related diabetes
A New Biology of Diabetes Revealed by Leptin
IL-6 Muscles In on the Gut and Pancreas to Enhance Insulin Secretion
Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes
The Stunned β Cell: A Brief History
VEGF-B Improves Metabolic Health through Vascular Pruning of Fat
Volume 25, Issue 6, Pages e8 (June 2017)
Maria Sara Remedi, Colin G. Nichols  Cell Metabolism 
Is Growth Hormone Resistance/IGF-1 Reduction Good for You?
Silencing Insulin Resistance through SIRT1
Estrogen Receptors and the Metabolic Network
Volume 11, Issue 3, Pages (March 2010)
Pancreas and Not Gut Mediates the GLP-1-Induced Glucoincretin Effect
The HETE Is on FFAR1 and Pancreatic Islet Cells
Dietary Carbohydrates Impair Healthspan and Promote Mortality
Insulin Action under Arrestin
p38δ and PKD1: Kinase Switches for Insulin Secretion
Timothy R. Donahue, David W. Dawson  Cell Stem Cell 
IL-1 Can Act as Number One
Fly-let Biology and the High Protein/Low Carb Diet
Volume 24, Issue 4, Pages (October 2016)
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 7, Issue 1, Pages (January 2008)
Volume 14, Issue 2, Pages (August 2011)
An IRKO in the Podo: Impaired Insulin Signaling in Podocytes and the Pathogenesis of Diabetic Nephropathy  Susan B. Gurley, Thomas M. Coffman  Cell Metabolism 
Models of the mechanisms by which sulfonylureas and glucose control glucagon release. Models of the mechanisms by which sulfonylureas and glucose control.
Collecting new targets in MODY
Oxytocin: The Neuropeptide of Love Reveals Some of Its Secrets
Role reversal: Brain insulin and liver STAT3
Benjamin P. Garfinkel, Gökhan S. Hotamisligil  Molecular Cell 
All Roads Lead to the Ribosome
Hap1 and GABA: Thinking about food intake
Of Fat, β Cells, and Diabetes
BDNF (I)rising from Exercise
IL-1β Activation as a Response to Metabolic Disturbances
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Ringing the dinner bell for insulin: Muscarinic M3 receptor activity in the control of pancreatic β cell function  Jesper Gromada, Thomas E. Hughes  Cell.
One Small Step for Muscle: A New Micropeptide Regulates Performance
Presentation transcript:

The Insulin Receptor Talks to Glucagon? Jesper Gromada, Alokesh Duttaroy, Patrik Rorsman  Cell Metabolism  Volume 9, Issue 4, Pages 303-305 (April 2009) DOI: 10.1016/j.cmet.2009.03.008 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Plasma Insulin, Glucagon, and Glucose Levels in Response to a Meal in Healthy Individual and Patients with T2DM Blood glucose levels are regulated by carefully orchestrated changes of insulin and glucagon secretion in response to carbohydrate meal ingestion in healthy individuals (Normal). An increased plasma glucose (left) following meal evokes insulin secretion from the β cells (middle); insulin secretion in individuals with T2DM is reduced (red-dotted line). Glucagon secretion is normally suppressed by the elevation of plasma glucose (right; blue line). In diabetic patients, the suppressor effect of glucose is reduced, and it may even stimulate glucagon release (right; red line). Data adapted from Dunning and Gerich (2007). Cell Metabolism 2009 9, 303-305DOI: (10.1016/j.cmet.2009.03.008) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Regulation of Glucagon by Insulin in Pancreatic α Cells In normal α cells, glucagon secretion is controlled by autocrine and paracrine processes (left). In addition, glucagon secretion is regulated by intrinsic α cell mechanisms (not shown). Increased glucose levels cause insulin release from β cell that activates α cell insulin receptor (IR). This activates PI3K/AKT pathway to open either KATP channels or recruitment of GABA-activated GABA receptor Cl− channels (GABA R; channels that are activated by GABA released from neighboring β cells). Both processes culminate in membrane hyperpolarization and inhibition of glucagon release. In patients with T2DM (middle), reduced insulin secretion leads to less activation of α cell insulin receptors and downstream processes will be correspondingly reduced, causing oversecretion of glucagon. In αIRKO islets (right) insulin signaling is abolished, and the relief from the paracrine suppression normally exerted via the insulin receptors account for stimulation of glucagon secretion. Cell Metabolism 2009 9, 303-305DOI: (10.1016/j.cmet.2009.03.008) Copyright © 2009 Elsevier Inc. Terms and Conditions